| Ogles Oxygen Llc | |
| 5901 Goshen Springs Rd, Ste G, Norcross, Georgia 30071 | |
| (770) 449-6898 |
| Name | Ogles Oxygen Llc |
|---|---|
| Organization Name | Ogles Oxygen, Llc |
| Location | 5901 Goshen Springs Rd, Ste G, Norcross, Georgia 30071 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (770) 449-6898 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 7,912,000 shares of its common stock, including 1,032,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. Net proceeds were approximately $44.4 million after deducting underwriting discounts and estimated offering expenses. Jefferies & Company, Inc. acted as the sole book-running manager and Canaccord Genuity Inc. acted as co-lead manager for the offering.
Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.
Guthrie is professor of Public Policy and Education; director, Peabody Center for Education Policy; and chair, Department of Leadership, Policy and Organizations at Vanderbilt's Peabody College.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.
› Verified 5 days ago
| NPI Number | 1497387260 |
| Organization Name | OGLES OXYGEN, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5901 Goshen Springs Rd Ste G, Norcross, GA 30071 |
| Phone Number | 770-449-6898 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 7,912,000 shares of its common stock, including 1,032,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. Net proceeds were approximately $44.4 million after deducting underwriting discounts and estimated offering expenses. Jefferies & Company, Inc. acted as the sole book-running manager and Canaccord Genuity Inc. acted as co-lead manager for the offering.
Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.
Guthrie is professor of Public Policy and Education; director, Peabody Center for Education Policy; and chair, Department of Leadership, Policy and Organizations at Vanderbilt's Peabody College.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.
› Verified 5 days ago
| NPI Number | 1528036753 |
| Organization Name | EXTRAKARE, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3250 Peachtree Corners Cir, Suite A, Norcross, GA 30092 |
| Phone Number | 770-449-6898 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 7,912,000 shares of its common stock, including 1,032,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. Net proceeds were approximately $44.4 million after deducting underwriting discounts and estimated offering expenses. Jefferies & Company, Inc. acted as the sole book-running manager and Canaccord Genuity Inc. acted as co-lead manager for the offering.
Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.
Guthrie is professor of Public Policy and Education; director, Peabody Center for Education Policy; and chair, Department of Leadership, Policy and Organizations at Vanderbilt's Peabody College.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.
› Verified 5 days ago
| NPI Number | 1851721047 |
| Organization Name | ADVANCED HOME CARE INC |
| Type | Home Infusion Therapy Pharmacy |
| Address | 5901 Goshen Springs Rd, Ste G, Norcross, GA 30071 |
| Phone Number | 770-449-6898 |
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 7,912,000 shares of its common stock, including 1,032,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. Net proceeds were approximately $44.4 million after deducting underwriting discounts and estimated offering expenses. Jefferies & Company, Inc. acted as the sole book-running manager and Canaccord Genuity Inc. acted as co-lead manager for the offering.
Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.
Guthrie is professor of Public Policy and Education; director, Peabody Center for Education Policy; and chair, Department of Leadership, Policy and Organizations at Vanderbilt's Peabody College.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.
› Verified 5 days ago
News Archive
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 7,912,000 shares of its common stock, including 1,032,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. Net proceeds were approximately $44.4 million after deducting underwriting discounts and estimated offering expenses. Jefferies & Company, Inc. acted as the sole book-running manager and Canaccord Genuity Inc. acted as co-lead manager for the offering.
Sunbathers have long known that melanin in their skin cells provides protection from the damage caused by visible and ultraviolet light. More recent studies have shown that melanin, which is produced by multitudes of the planet's life forms, also gives some species protection from ionizing radiation. In certain microbes, in particular some organisms from near the former nuclear reactor facilities in Chernobyl, melanin has even been linked to increased growth in the presence of ionizing radiation.
Guthrie is professor of Public Policy and Education; director, Peabody Center for Education Policy; and chair, Department of Leadership, Policy and Organizations at Vanderbilt's Peabody College.
Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease.
› Verified 5 days ago
Accredo Health Group Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 190 Technology Pkwy, Norcross, Georgia 30092 Phone: (800) 310-7995 | |
Advanced Home Infusion Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5901 Goshen Springs Rd, Norcross, Georgia 30071 Phone: (770) 500-3834 | |
Cvs Pharmacy #02108 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5095 Peachtree Pkwy, Norcross, Georgia 30092 Phone: (770) 209-9299 | |
Cvs Pharmacy #02228 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5304 Buford Hwy, Norcross, Georgia 30071 Phone: (770) 209-0296 | |
Cvs Pharmacy #05646 Type: Medicare Supplier Location: 7734 Spalding Dr, Norcross, Georgia 30092 Phone: (770) 447-9096 |